Midday movers: AbbVie, Barrick Gold, Clorox & more

Wall Street New York Stock Exchange NYSE
Scott Mlyn | CNBC

Take a look at some of Thursday's midday movers:

AbbVie - The drug maker gained after reporting quarterly revenue well above street expectations.

Aegerion Pharmaceuticals - The biopharmaceutical company plummeted after reporting a third-quarter loss and significantly decreasing its 2014 full-year guidance. Jefferies downgraded the stock to hold from buy.

Barrick Gold - The gold producer and competitors including Newmont Mining, AngloGold Ashanti and Yamana Gold fell along with the price of the precious metal.

Chevron - The oil producer rose after reporting a bigger-than-expected quarterly profit.

Clorox - The maker of cleaning products edged higher after posting better-than-expected quarterly sales.

Exxon Mobil - The oil producer climbed after reporting a better-than-expected third-quarter profit.

Gilead Sciences - The drug maker fell on weaker-than-expected sales of its treatment for Hepatitis C.

Honeywell International - The manufacturer edged up after increasing its annual dividend to $2.07 a share.

Mead Johnson Nutrition - The maker of infant formula fell on news French food company Danone purchased a $566 million stake in a Chinese infant formula maker, dampening speculation it would try to acquire Mead Johnson.

Priceline Group - The online travel company and rival Orbitz Worldwide gained on Expedia's strong earnings.

Rockwell Collins - The maker of aircraft systems rose after reporting quarterly sales increased by about 15 percent year over year.

Sony - The maker of electronic equipment rose after posting a smaller-than-expected operating loss in its second quarter.

United Continental Holdings - The carrier and others including Delta Air Lines, American Airlines Group, Spirit Airlines and Southwest Airlines rose as oil prices fell.

Visa - The payment processing company rose after Argus Research upgraded the stock to buy from hold.

(See CNBC's Market Insider Blog)

Questions? Comments? Email us at marketinsider@cnbc.com